Fig. 3: Rapamycin-mediated immune modulation in monkeys—ADAs. | Nature Communications

Fig. 3: Rapamycin-mediated immune modulation in monkeys—ADAs.

From: Transient rapamycin treatment avoids unwanted host immune responses toward AAV-delivered anti-HIV antibodies

Fig. 3: Rapamycin-mediated immune modulation in monkeys—ADAs.The alternative text for this image may have been generated using AI.

The five rhesus macaques from Fig. 2 that received three AAV9 vectors were monitored for ADAs in serum. ADAs to a C-rh 3BNC117, b C-rh 10-1074, and c C-rh PGT145. d Reactivity to the AAV9 capsid in serum. Abbreviations: LOD limit of detection. Source data are provided as a Source Data file.

Back to article page